KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Other financing activities (2016 - 2025)

AbbVie (ABBV) has disclosed Other financing activities for 14 consecutive years, with $45.0 million as the latest value for Q4 2025.

  • Quarterly Other financing activities rose 207.14% to $45.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $68.0 million through Dec 2025, up 19.3% year-over-year, with the annual reading at $68.0 million for FY2025, 19.3% up from the prior year.
  • Other financing activities for Q4 2025 was $45.0 million at AbbVie, up from $3.0 million in the prior quarter.
  • The five-year high for Other financing activities was $99.0 million in Q1 2024, with the low at -$75.0 million in Q2 2024.
  • Average Other financing activities over 5 years is $12.6 million, with a median of $10.0 million recorded in 2021.
  • Peak annual rise in Other financing activities hit 625.0% in 2022, while the deepest fall reached 650.0% in 2022.
  • Over 5 years, Other financing activities stood at $2.0 million in 2021, then tumbled by 650.0% to -$11.0 million in 2022, then skyrocketed by 536.36% to $48.0 million in 2023, then tumbled by 187.5% to -$42.0 million in 2024, then soared by 207.14% to $45.0 million in 2025.
  • According to Business Quant data, Other financing activities over the past three periods came in at $45.0 million, $3.0 million, and $20.0 million for Q4 2025, Q2 2025, and Q1 2025 respectively.